Quantitative apparent diffusion coefficient measurement obtained by 3.0 Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer Journal Article
| Authors: | Durando, M.; Gennaro, L.; Cho, G. Y.; Giri, D. D.; Gnanasigamani, M. M.; Patil, S.; Sutton, E. J.; Deasy, J. O.; Morris, E. A.; Thakur, S. B. |
| Article Title: | Quantitative apparent diffusion coefficient measurement obtained by 3.0 Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer |
| Abstract: | Purpose To assess the association between apparent diffusion coefficient (ADC), and histological prognostic parameters in malignant breast lesions. The ability of ADC to identify lesions with the presence of Lymphovascular invasion (LVI) in breast carcinoma was also examined. Materials and methods This HIPAA-compliant retrospective study consisted of 212 consecutive patients with known cancers who underwent 3.0 T MRI between January 2011 and 2013. In this study, a total of 126 malignant lesions in 114 women, who had undergone DWI (b-values of 0 and 1000 s/mm2) in addition to diagnostic MRI, were included. Patients with less than 0.8 cm lesions, or those who underwent neoadjuvant chemotherapy or suboptimal DW images were excluded. Classical prognostic factors [lesion size, histopathological type and grade, lymph node (LN) status and lymphovascular invasion (LVI)], molecular prognostic markers [estrogen receptor (ER), progesterone receptor (PR) and human epidermal grow factor receptor 2 (HER2)] were reviewed and recorded. A region of interest (ROI) was drawn within the lesions to measure ADC values. Statistical analyses were performed by the Wilcoxon rank sum test (statistical significance at P < 0.05). Adjusted p values from multiple comparison analysis were also calculated. Results This study demonstrates an inverse correlation between ADC and LVI in malignant lesions and the ability of ADC to identify aggressiveness in lesions with positive LVI. Tumor size, grade, ER, PR, HER2 and lymph node status did not impact tumor ADC value. However, tumors with LVI showed significantly lower ADC values when compared to tumors without LVI, regardless of the enhancement type, histological grade, histological type, and LN status. Conclusion Our study shows that ADC could be a potential clinical adjunct in the evaluation of prognostic factors related to malignant lesion aggressiveness such as LVI. © 2016 Elsevier Ireland Ltd |
| Keywords: | lymph nodes; breast cancer; prognostic factors; lymphovascular invasion; dw-mri at 3.0t |
| Journal Title: | European Journal of Radiology |
| Volume: | 85 |
| Issue: | 9 |
| ISSN: | 0720-048X |
| Publisher: | Elsevier B.V |
| Date Published: | 2016-09-01 |
| Start Page: | 1651 |
| End Page: | 1658 |
| Language: | English |
| DOI: | 10.1016/j.ejrad.2016.06.019 |
| PROVIDER: | scopus |
| PUBMED: | 27501902 |
| PMCID: | PMC5505563 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 2 August 2016 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work